Pharmacokinetics of a Single-Dose of Dalbavancin in Preterm Neonates to Infants Ages 3 Months with Suspected or Confirmed Bacterial Infection

Administered By

Awarded By

Contributors

Start/End

  • March 1, 2016 - November 6, 2019